Blue Edge Capital LLC lessened its holdings in Aetna Inc (NYSE:AET) by 5.4% during the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 9,923 shares of the company’s stock after selling 567 shares during the quarter. Blue Edge Capital LLC’s holdings in Aetna were worth $1,578,000 as of its most recent filing with the Securities & Exchange Commission.
A number of other institutional investors have also made changes to their positions in the business. Wedbush Securities Inc. grew its position in shares of Aetna by 1.4% during the 2nd quarter. Wedbush Securities Inc. now owns 3,779 shares of the company’s stock worth $574,000 after buying an additional 52 shares in the last quarter. Calamos Wealth Management LLC grew its position in shares of Aetna by 0.7% during the 2nd quarter. Calamos Wealth Management LLC now owns 8,919 shares of the company’s stock worth $1,354,000 after buying an additional 65 shares in the last quarter. Sigma Planning Corp grew its position in shares of Aetna by 2.6% during the 2nd quarter. Sigma Planning Corp now owns 2,702 shares of the company’s stock worth $410,000 after buying an additional 69 shares in the last quarter. UMB Bank N A MO grew its position in shares of Aetna by 1.0% during the 2nd quarter. UMB Bank N A MO now owns 7,601 shares of the company’s stock worth $1,154,000 after buying an additional 74 shares in the last quarter. Finally, FCA Corp TX grew its position in shares of Aetna by 0.7% during the 2nd quarter. FCA Corp TX now owns 12,230 shares of the company’s stock worth $1,857,000 after buying an additional 80 shares in the last quarter. 88.01% of the stock is currently owned by institutional investors.
Shares of Aetna Inc (NYSE:AET) opened at $182.73 on Monday. The company has a quick ratio of 0.53, a current ratio of 0.53 and a debt-to-equity ratio of 0.52. Aetna Inc has a 12 month low of $116.04 and a 12 month high of $192.37. The company has a market capitalization of $59,590.00, a PE ratio of 17.90, a price-to-earnings-growth ratio of 1.67 and a beta of 0.61.
Aetna (NYSE:AET) last released its quarterly earnings results on Tuesday, October 31st. The company reported $2.45 EPS for the quarter, beating analysts’ consensus estimates of $2.06 by $0.39. Aetna had a return on equity of 21.84% and a net margin of 2.93%. The company had revenue of $14.99 billion during the quarter, compared to analysts’ expectations of $15.12 billion. During the same period last year, the business posted $2.07 earnings per share. The firm’s revenue was down 5.0% compared to the same quarter last year. equities research analysts predict that Aetna Inc will post 9.78 EPS for the current year.
The firm also recently declared a quarterly dividend, which will be paid on Friday, January 26th. Shareholders of record on Thursday, January 11th will be paid a $0.50 dividend. This represents a $2.00 dividend on an annualized basis and a yield of 1.09%. The ex-dividend date of this dividend is Wednesday, January 10th. Aetna’s dividend payout ratio (DPR) is presently 36.97%.
In other Aetna news, President Karen S. Lynch sold 15,271 shares of the stock in a transaction dated Monday, September 18th. The stock was sold at an average price of $161.91, for a total value of $2,472,527.61. Following the completion of the sale, the president now directly owns 64,261 shares in the company, valued at $10,404,498.51. The transaction was disclosed in a document filed with the SEC, which is available at this link. Also, EVP Margaret M. Mccarthy sold 10,288 shares of the stock in a transaction dated Friday, September 15th. The shares were sold at an average price of $162.85, for a total value of $1,675,400.80. Following the completion of the sale, the executive vice president now owns 33,563 shares of the company’s stock, valued at $5,465,734.55. The disclosure for this sale can be found here. Company insiders own 1.14% of the company’s stock.
A number of equities analysts have recently issued reports on the company. Wells Fargo & Company reissued an “outperform” rating and set a $208.00 price target (up previously from $200.00) on shares of Aetna in a research report on Monday, December 4th. Argus downgraded Aetna from a “buy” rating to a “hold” rating and set a $185.00 price target on the stock. in a research report on Wednesday, December 6th. Credit Suisse Group reissued a “neutral” rating and set a $195.00 price target (up previously from $174.00) on shares of Aetna in a research report on Wednesday, December 6th. BMO Capital Markets raised their price objective on Aetna from $175.00 to $200.00 and gave the company a “market perform” rating in a research report on Friday, October 27th. Finally, Cantor Fitzgerald downgraded Aetna from an “overweight” rating to a “neutral” rating in a research report on Thursday, October 26th. Twelve investment analysts have rated the stock with a hold rating and fourteen have given a buy rating to the stock. The company has a consensus rating of “Buy” and an average target price of $175.19.
TRADEMARK VIOLATION NOTICE: “Aetna Inc (AET) Shares Sold by Blue Edge Capital LLC” was reported by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are viewing this news story on another website, it was stolen and reposted in violation of US & international copyright and trademark legislation. The legal version of this news story can be accessed at https://www.dispatchtribunal.com/2017/12/11/aetna-inc-aet-shares-sold-by-blue-edge-capital-llc.html.
Aetna Inc is a diversified healthcare benefits company. The Company operates through three segments: Health Care, Group Insurance and Large Case Pensions. It offers a range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental, behavioral health, group life and disability plans, medical management capabilities, Medicaid healthcare management services, Medicare Advantage and Medicare Supplement plans, workers’ compensation administrative services and health information technology (HIT) products and services.
Want to see what other hedge funds are holding AET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Aetna Inc (NYSE:AET).
Receive News & Ratings for Aetna Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aetna Inc and related companies with MarketBeat.com's FREE daily email newsletter.